Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mannix, K.
Right arrow Articles by Wilcock, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mannix, K.
Right arrow Articles by Wilcock, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Using bisphosphonates to control the pain of bone metastases: evidence-based guidelines for palliative care

Kathryn Mannix

Sam Hjelmeland Ahmedzai

Royal Hallamshire Hospital, Sheffield

Heather Anderson

Michael Bennett

Palliative Medicine, St Gemma's Hospice, Leeds

Mari Lloyd-Williams

Palliative Medicine, Leicestershire Hospice, Leicester

Andrew Wilcock

Palliative Medicine and Oncology, Hayward House Palliative Care Unit, Nottingham

This work was undertaken by the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland (APM) as a demonstration project in developing clinical guidelines relevant to palliative care from a pragmatic approach to literature review and grading of clinical evidence. CANCERLIT and Embase were searched for relevant papers written in English, published since 1980. Each study identified was rated against agreed criteria for levels of evidence. Most studies were not specifically designed to define speed of response, and were not undertaken in palliative care patients. Thus, careful reading and grading of each study was necessary. Sufficient evidence was identified to make recommendations for clinical practice in a palliative care population of patients, and areas for future research have been identified. Bisphosphonates appear to have a role in managing pain from metastases which has been refractory to conventional analgesic management and where oncological or orthopaedic intervention is delayed or inappropriate.

Key Words: pain relief • bone metastases • bisphosphonates • clinical guidelines

Palliative Medicine, Vol. 14, No. 6, 455-461 (2000)
DOI: 10.1191/026921600701536372
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Palliat MedHome page
R. George and J. Hephzibah
Letter to the editor: Does pamidronate enhance the analgesic effect of radiotherapy? A randomized trail
Palliative Medicine, December 1, 2007; 21(8): 719 - 720.
[PDF]

Home page
 Br Med BullHome page
J. C. Thompson, J. Wood, and D. Feuer
Prostate cancer: palliative care and pain relief
Br. Med. Bull., September 1, 2007; 83(1): 341 - 354.
[Abstract] [Full Text] [PDF]

Home page
 JDRHome page
R. Benoliel, J. Epstein, E. Eliav, R. Jurevic, and S. Elad
Orofacial Pain in Cancer: Part I--Mechanisms
Journal of Dental Research, June 1, 2007; 86(6): 491 - 505.
[Abstract] [Full Text] [PDF]

Home page
 Palliat MedHome page
P. W Keeley
Clinical guidelines
Palliative Medicine, June 1, 2003; 17(4): 368 - 374.
[Abstract] [PDF]